Jamieson Wellness (TSE:JWEL) Rating Lowered to Tender at Canadian Imperial Bank of Commerce

Jamieson Wellness (TSE:JWEL) was downgraded by equities researchers at Canadian Imperial Bank of Commerce from an “outperformer” rating to a “tender” rating in a research note issued on Friday,BayStreet.CA reports. They presently have a C$45.75 price objective on the stock, up from their prior price objective of C$44.00. Canadian Imperial Bank of Commerce’s target price points to a potential upside of 0.28% from the stock’s current price.

Jamieson Wellness Price Performance

JWEL stock traded up C$4.12 during mid-day trading on Friday, reaching C$45.62. 1,319,560 shares of the company traded hands, compared to its average volume of 97,442. The company has a fifty day moving average price of C$39.42 and a 200-day moving average price of C$36.69. Jamieson Wellness has a 52-week low of C$32.54 and a 52-week high of C$45.65. The company has a market capitalization of C$1.89 billion, a P/E ratio of 26.37 and a beta of 1.48. The company has a debt-to-equity ratio of 96.64, a current ratio of 3.58 and a quick ratio of 1.08.

Jamieson Wellness (TSE:JWEL) last released its quarterly earnings data on Thursday, August 6th. The company reported C$0.46 EPS for the quarter. The company had revenue of C$233.84 million during the quarter. Jamieson Wellness had a net margin of 8.71% and a return on equity of 15.25%. As a group, analysts anticipate that Jamieson Wellness will post 2.1438892 earnings per share for the current year.

Jamieson Wellness Company Profile

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.